Diagnostic Medical Systems S.A.
ALDMS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €46 | €44 | €35 | €36 |
| % Growth | 4.4% | 25.1% | -2.8% | – |
| Cost of Goods Sold | €28 | €28 | €21 | €23 |
| Gross Profit | €18 | €16 | €14 | €14 |
| % Margin | 39.9% | 36.3% | 39.2% | 38.3% |
| R&D Expenses | €0 | €2 | €2 | €3 |
| G&A Expenses | €0 | €0 | €0 | €6 |
| SG&A Expenses | €0 | -€2 | -€2 | €6 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €19 | €0 | €16 | €6 |
| Operating Expenses | €19 | €0 | €16 | €14 |
| Operating Income | -€0 | -€2 | -€6 | -€1 |
| % Margin | -0.8% | -5.1% | -16.7% | -2.3% |
| Other Income/Exp. Net | -€2 | -€8 | -€1 | -€2 |
| Pre-Tax Income | -€3 | -€10 | -€7 | -€3 |
| Tax Expense | €0 | €0 | €0 | €0 |
| Net Income | -€3 | -€5 | -€7 | -€4 |
| % Margin | -6.3% | -11.2% | -19.3% | -10.7% |
| EPS | -0.16 | -0.56 | -0.42 | -0.24 |
| % Growth | 71.4% | -33.3% | -75% | – |
| EPS Diluted | -0.16 | -0.56 | -0.42 | -0.24 |
| Weighted Avg Shares Out | 18 | 17 | 16 | 16 |
| Weighted Avg Shares Out Dil | 18 | 17 | 16 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €2 | €0 | €0 | €0 |
| Depreciation & Amortization | €3 | €2 | €2 | €2 |
| EBITDA | -€0 | €1 | -€4 | -€0 |
| % Margin | -0.4% | 1.9% | -12.1% | -1% |